Conference Coverage (AASLD)
Small Dose of HEV Results in Subclinical Infection
Published in Medical Letter on the CDC and FDA, November 30th, 1998
Researcher Rakesh Aggarwal and colleagues found that a high dose of exposure to the fecal inoculum which causes hepatitis E virus (HEV) causes clinically evident infection and a low dose lead to subclinical infection.
They added, however, that subclinical HEV infection is associated with viral excretion of the same magnitude as clinical infection, suggesting a role for subclinical infection in the transmission of HEV.
Aggarwal presented...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Public Health
Home HIV Tests Reaching High-Risk Individuals - T. cruzi
Blood Donor Management Strategies May Need Revision - At-Risk Populations
Protease Inhibitor-Treated Patients More Likely To Engage in Risky Sex - Dengue Fever (Vaccine Development)
Thai Scientists Moving Forward in Battle Against Dengue - Heart Disease (Epidemiology)
Gap Between Races Growing in Heart Disease Deaths - Opportunistic Infections
"Entamoeba histolytica Infections Among HIV Infected Patients in the United States: Clinical Presentation, Diagnostic Methods, and Treatment Choices." - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
